跳至主要内容
临床试验/ITMCTR2100005453
ITMCTR2100005453招募中4 期

To evaluate the clinical mechanism of Lian-Hua Qing-Wen capsule on systemic immune regulation of influenza patients

Ruijin Hospital, Shanghai Jiaotong University School of Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 69(—)
性别
All

入选标准

  • 1. Meet the influenza clinical diagnosis criteria of Influenza Diagnosis and Treatment Protocol (2020 Edition);
  • 2.18 = age < 70;
  • 3. Fever duration =48h, maximum axillary temperature =38.5?;
  • 4. Pharyngeal swabs tested positive for influenza virus rapid antigen.
  • 5. Signed the informed consent, and the informed consent process was in accordance with the provisions.
  • 6. Flu patients who have received COVID-19 vaccine for more than a month.

排除标准

  • 1. Comply with the epidemic cold diagnosis and treatment plan (2020 edition) influenza clinical diagnosis criteria;
  • 2.18 years old = age <70 years old;
  • 3. The heating process is =48h, the highest underarm temperature = 38.5 ° C;
  • 4. Positive antigen detection of throat swab influenza virus;
  • 5. Sign the informed consent, the informed consent process meets the requirements;
  • 6. Injection of neoguan vaccine patients more than 1 month of flu patients.

研究者

发起方
Ruijin Hospital, Shanghai Jiaotong University School of Medicine

相似试验